Brief: Biolase Posts Q4 Revenue Of $48.5 Mln

November 26

28/03/2023 21:29

March 28 (Reuters) - Biolase Inc  BIOL.O :
    * BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS
GO-TO-MARKET
STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH
AND PROFITABILITY IN 2023
    * Q4 REVENUE ROSE 24 PERCENT TO $48.5 MILLION
    * ANTICIPATING FIRST-QUARTER NET REVENUE TO EXCEED $10.0
MILLION
    * QTRLY LOSS PER SHARE $1.28
    * Q4 EARNINGS PER SHARE VIEW $-0.64, REVENUE VIEW $14.1
MILLION --
REFINITIV IBES DATA
    * Q1 REVENUE VIEW $12.2 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPngGVXwa 
Further company coverage:  BIOL.O 

 ((Reuters.Briefs@thomsonreuters.com;))